Optimum and stepped care standardised antihypertensive treatment with or without renal denervation for resistant hypertension (DENERHTN): a multicentre, open-label, randomised controlled trial
Azizi, Michel, Prof, Sapoval, Marc, Prof, Gosse, Philippe, MD, Monge, Matthieu, MD, Bobrie, Guillaume, MD, Delsart, Pascal, MD, Midulla, Marco, MD, Mounier-Véhier, Claire, Prof, Courand, Pierre-Yves, MD, Lantelme, Pierre, Prof, Denolle, Thierry, MD, Dourmap-Collas, Caroline, MD, Trillaud, Hervé, Prof, Pereira, Helena, MSc, Plouin, Pierre-François, Prof, Chatellier, Gilles, Prof
Published in The Lancet (British edition) (16.05.2015)
Published in The Lancet (British edition) (16.05.2015)
Get full text
Journal Article
I-COMBINE Study: Assessment of Efficacy and Safety Profile of Irbesartan/Amlodipine Fixed-Dose Combination Therapy Compared With Amlodipine Monotherapy in Hypertensive Patients Uncontrolled With Amlodipine 5 mg Monotherapy: A Multicenter, Phase III, Prospective, Randomized, Open-Label With Blinded–End Point Evaluation Study
Get full text
Journal Article
I-ADD Study: Assessment of Efficacy and Safety Profile of Irbesartan/Amlodipine Fixed-Dose Combination Therapy Compared With Irbesartan Monotherapy in Hypertensive Patients Uncontrolled With Irbesartan 150 mg Monotherapy: A Multicenter, Phase III, Prospective, Randomized, Open-Label With Blinded–End Point Evaluation Study
Get full text
Journal Article
Eligibility for Renal Denervation in Patients With Resistant Hypertension
Savard, Sébastien, MD, MSc, Frank, Michael, MD, MSc, Bobrie, Guillaume, MD, Plouin, Pierre-François, MD, Sapoval, Marc, MD, PhD, Azizi, Michel, MD, PhD
Published in Journal of the American College of Cardiology (11.12.2012)
Published in Journal of the American College of Cardiology (11.12.2012)
Get full text
Journal Article